FIND ANNOUNCES NEW WAVE OF ACTIVITIES TO ADDRESS HCV ELIMINATION

The Foundation for Innovative New Diagnostics (FIND) announced last Friday that it has awarded grants to a number of companies to address the urgent diagnostic needs for hepatitis C virus (HCV). These grants will be used to conduct feasibility studies of various technologies that could transform HCV testing at the point of care. Mologic is among the companies receiving support to develop and validate prototype HCV core antigen (cAg) tests on their innovative rapid diagnostic test platform. Read more on the official website: https://www.finddx.org/news/find-announces-new-wave-activities-addressing-challenges-threatening-hepc-elimination/

Lab statistics

image for Visitors Greeted
Visitors Greeted

212

in the last month

image for Hours in the lab
Hours in the lab

67500

so far this year

image for Problems solved
Problems solved

79

this year

image for Assays completed
Assays completed

2700

this month

EXPLORE WHAT WE CAN DO AT MOLOGIC

Take a look at our expertise. And if you can't see exactly what you're after, contact us. We'll be delighted to discuss your project with you.

Contact us